W

Wellgistics Health Inc
NASDAQ:WGRX

Watchlist Manager
Wellgistics Health Inc
NASDAQ:WGRX
Watchlist
Price: 0.1084 USD -1.45% Market Closed
Market Cap: $13.8m

Wellgistics Health Inc
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Wellgistics Health Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
W
Wellgistics Health Inc
NASDAQ:WGRX
Cost of Revenue
-29.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oracle Corp
NYSE:ORCL
Cost of Revenue
-$21.1B
CAGR 3-Years
-20%
CAGR 5-Years
-22%
CAGR 10-Years
-11%
Palantir Technologies Inc
NASDAQ:PLTR
Cost of Revenue
-$789.2m
CAGR 3-Years
-25%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Intuit Inc
NASDAQ:INTU
Cost of Revenue
-$4B
CAGR 3-Years
-12%
CAGR 5-Years
-24%
CAGR 10-Years
-19%
Adobe Inc
NASDAQ:ADBE
Cost of Revenue
-$2.6B
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-13%
Microsoft Corp
NASDAQ:MSFT
Cost of Revenue
-$100.9B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
No Stocks Found

Wellgistics Health Inc
Glance View

Market Cap
13.8m USD
Industry
N/A

Wellgistics Health Inc is a US-based company operating in industry. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

WGRX Intrinsic Value
Not Available
W

See Also

What is Wellgistics Health Inc's Cost of Revenue?
Cost of Revenue
-29.8m

Based on the financial report for Dec 31, 2025, Wellgistics Health Inc's Cost of Revenue amounts to -29.8m .

What is Wellgistics Health Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-82%

Over the last year, the Cost of Revenue growth was -82%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett